Melanoma antigens tumor antigen antigen of tumor. Medical search. Frequent questions

T lymphocytes are cells of the immune system that attack and destroy virus-infected cells, tumor cells and cells from transplanted organs. (wikipedia.org)
In other instances, the normal peptide is presented at the cell surface and consequently the T lymphocytes that recognize the antigen have been eliminated by the central tolerance process that occurs in the thymus. (wikipedia.org)
In certain cases, tumor-infiltrating lymphocytes could also be assessed for such responses. (bmj.com)
Human primary tumor cells could also be reprogrammed to increase their capability to present antigen and to activate patient-specific tumor-infiltrating lymphocytes. (lu.se)
In this respect, we have previously identified two melanoma antigens, namely MELOE-1 and MELOE-2, that were recognized by tumor-infiltrating lymphocytes (TIL) from HLA-A0201+ patients who remained relapse-free following TIL transfer in an adjuvant setting [ 3 ]. (oncotarget.com)
In these pioneering studies by Steven Rosenberg, tumour-infiltrating lymphocytes (TILs) were isolated from patients with melanoma, then activated and expanded before reinfusion into the patients. (nature.com)

Some genes are expressed by tumor cells and not by normal cells. (wikipedia.org)
A class of genes, named cancer-germline genes, is expressed in a large variety of cancer cells but not in normal cells, with the exception of germline cells, which do not carry MHC molecules on their surface and therefore do not present the antigens. (wikipedia.org)
Mutated genes contribute greatly to the immunogenicity of human tumors. (wikipedia.org)
In cancer patients, about one half of the highly tumor-specific antigens recognized by spontaneous T cell responses are encoded by mutated genes, the other half being encoded by cancer-germline genes. (wikipedia.org)
Cancer-germline genes are an important source of tumor-specific antigens. (wikipedia.org)
These genes are expressed in a significant fraction of tumors of many different histological types. (wikipedia.org)
Although epigenetically silenced, endogenous retroviral (ERV) genes become activated in tumors and function to ignite immune responses. (frontiersin.org)
Jawed vertebrates (gnathostomes) generate a diverse repertoire of B and T cell antigen receptors through the rearrangement of immunoglobulin V, D, and J gene fragments, whereas jawless fish (agnathans) assemble diverse lymphocyte antigen receptor genes through the genomic rearrangement of leucine-rich repeat (LRR) - encoding molecules. (scielo.br)
p21 and other tumor suppressor genes' inactivation are therefore most likely involved in the first steps of the cancer model, with later stages possibly involving protooncogene activation and inflammation. (medscape.com)

Skin cancers are the most common cancers, and malignant melanoma is the most serious form of skin cancer. (medscape.com)
Malignant melanoma is known to be a relatively chemoresistant tumor. (medscape.com)
In melanoma, the malignant black skin cancer, such T-cell receptor transgenic T cells have already been shown to prolong the lives of some patients. (dkfz.de)
Choroidal melanoma is the most common primary malignant ocular tumor in human adults. (molvis.org)
Patients with oral malignant melanoma often recall having an existing oral pigmentation months to years before diagnosis, and the condition may even have elicited prior comment from examining physicians and dentists (or healthcare providers, when considering the auxiliaries). (medscape.com)
From the article: 'An estimated 325,000 new cases of malignant melanoma were diagnosed worldwide in 2020. (cdc.gov)

The contribution of these antigens to tumor immunogenicity is expected to vary according to the mutation rate: higher in lung carcinomas arising in tobacco smokers, in melanomas owing to mutations induced by UV and in the 15% of colorectal carcinomas that have hypermutated DNA owing to defects in the DNA mismatch repair pathway. (wikipedia.org)
In contrast, melanoma-restricted expression of IRES-dependent MELOE-1 may explain its high immunogenicity. (oncotarget.com)

Background Anti-programmed cell death protein 1 (PD-1) antibodies are now routinely administered for metastatic melanoma and for increasing numbers of other cancers, but still only a fraction of patients respond. (bmj.com)
In the field of cancer immunotherapy, the recently described effectiveness of checkpoint inhibitors such as anti-PD1 blocking antibodies to boost anti-tumor T cell responses is very encouraging [ 1 ]. (oncotarget.com)
Tumor cells display a variety of antigens which have been defined by antibodies. (bdbiosciences.com)
Antibodies that specifically react with tumor-associated antigens are useful in understanding the biology of particular tumor types. (bdbiosciences.com)
Host Response to Tumors The immune response to foreign antigens consists of Humoral mechanisms (eg, antibodies) Cellular mechanisms (See also Tumor Antigens. (msdmanuals.com)
In the setting of cancer, instead of eliciting effector pathways that would lead to tumor elimination, these antibodies might promote down-regulation of the cellular inflammatory responses to the tumor. (scirp.org)

Whereas each T cell recognizes a single antigen, collectively the T cells are endowed with a large diversity of receptors targeted at a wide variety of antigens. (wikipedia.org)

The purpose of T cell-mediated cancer immunotherapy is to reactivate these responses to a degree that results in tumor destruction without causing harmful effects on normal cells. (wikipedia.org)
In conclusion, within the MELOE family, IRES-dependent antigens represent the best T cell targets for immunotherapy of melanoma. (oncotarget.com)
However, a significant number of patients are non responders to these therapies and thus, there is still room for improvement using antigen-specific immunotherapy, whether through vaccination or through T cell transfer. (oncotarget.com)
Scientists from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) successfully tested a new form of cellular immunotherapy against brain tumors in mice for the first time. (dkfz.de)
Personalized anti-cancer vaccine combining mRNA and immunotherapy tested in melanoma trial. (cdc.gov)
However, the frequency of melanoma is increasing, particularly in lighter-skinned people, and for the minority of patients diagnosed with metastatic disease, the 5-year survival rate is 35%, although the introduction of immunotherapy has doubled the median survival time for these patients. (cdc.gov)

Data from an exploratory analysis of the ongoing Phase 1 Lipo-MERIT monotherapy dose-escalation trial, the company has shown that BNT111 induces novel antigen-specific anti-tumor immune responses. (biospace.com)
Alternative inhibitory receptors have been identified that may be targeted for anti-tumor immune therapy, such as lymphocyte-activation gene-3 (LAG-3), as have several potential target oncogenes for molecularly targeted therapy, such as tyrosine kinase inhibitors. (biomedcentral.com)
Alternative inhibitory receptors have been identified that may also be targeted for anti-tumor immune therapy. (biomedcentral.com)

Antigenic peptides derived from the encoded proteins are therefore presented on the surface of tumor cells and not on normal cells. (wikipedia.org)
However, several antigens with selective expression on the surface of tumor cells are not associated with the major histocompatibility complex and may be candidates for therapeutic targeting. (msdmanuals.com)

It is now proven that tumor-specific antigens exist and that patients mount spontaneous T cell responses against such antigens. (wikipedia.org)
Healthy humans develop spontaneous CD8+ T cell responses to melanoma associated antigens (MA) expressed by normal melanocytes. (mdpi.com)
Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) (also known as CD152) is a major negative regulator of T cell responses which interacts with the B7-1 (CD80) / B7-2 (CD86) ligands on the surface of an antigen-presenting cell. (scielo.br)
Also, the trial data revealed that BNT111 enhanced pre-existing immune responses against the encoded melanoma-associated antigens. (biospace.com)
Most humoral responses cannot prevent tumor growth. (msdmanuals.com)
The mechanism by which vaccine adjuvants enhance immune responses has historically been considered to be the creation of an antigen depot. (mdpi.com)
Other successful studies quickly followed, such as those demonstrating sustained complete and partial responses in patients with melanoma and treatment of synovial cell sarcoma with TCR T cells against the NY-ESO-1 antigen. (nature.com)

They combined the variable region of an antibody with the constant regions of the TCR chains, thus producing chimeric antigen receptors (CARs) that provided T cells with antibody-type specificity. (nature.com)
After these initial studies had yielded such promising results, Lukas Bunse expects that vaccine-induced T-cell receptors targeting brain tumor antigens could be a promising approach to develop new immunotherapies against glioblastoma. (dkfz.de)
Outcomes for patients with melanoma have improved over the past decade with the clinical development and approval of immunotherapies targeting immune checkpoint receptors such as programmed death-1 (PD-1), programmed death ligand 1 (PD-L1) or cytotoxic T lymphocyte antigen-4 (CTLA-4). (biomedcentral.com)
These include the T cell immunoglobulin and mucin-domain containing-3 (TIM-3), lymphocyte-activation gene-3 (LAG-3), TIGIT, and B-and T-lymphocyte-associated protein (BTLA) receptors associated with T cell exhaustion and V-domain immunoglobulin suppressor of T cell activation (VISTA), a receptor found on tumor-infiltrating myeloid cells. (biomedcentral.com)

The American Academy of Dermatology has recognized Mohs micrographic surgery (MMS) as a useful technique for the treatment of melanoma, particularly of the face. (medscape.com)
What is the translational importance of alteration status in the treatment of melanoma brain metastases? (cdc.gov)

There a process named central tolerance eliminates the T cells that have a receptor recognizing an antigen present on normal cells of the organism. (wikipedia.org)
This enables the T cells to eliminate cells with "foreign" or "abnormal" antigens without harming the normal cells. (wikipedia.org)
It has long been debated whether cancer cells were bearing "tumor-specific" antigens, absent from normal cells, which could in principle cause the elimination of the tumor by the immune system. (wikipedia.org)
Hence, a new antigen is present only on the tumor cells. (wikipedia.org)
The recognition of mutation-induced antigens on tumors by T cells is only one aspect of a more general phenomenon which can rightly be named: T cell immunosurveillance of the integrity of the genome. (wikipedia.org)
Any somatic mutation has a probability of producing a new antigen that can be recognized by T cells. (wikipedia.org)
In some patients, the majority of the tumor-specific T cells recognize mutated antigens. (wikipedia.org)
We previously showed that the presence of NY-ESO-1-reactive and/or Melan-A-reactive T cells in the blood correlated with prolonged overall survival (OS) of patients with melanoma with a heterogeneous treatment background. (bmj.com)
Here, we investigated whether such reactive T cells can also be informative for clinical outcomes in metastatic melanoma under PD-1 immune-checkpoint blockade (ICB). (bmj.com)
An evaluation of melanoma tissue from selected cases suggested a correlation between tumor-resident NY-ESO-1- and Melan-A-reactive T cells and disease control, supporting the notion of a therapy-associated sequestration of cells from the periphery to the tumor predominantly in those patients benefitting from ICB. (bmj.com)
Cancer/testis antigen MAGEC2 (also known as HCA587) is highly expressed in a wide variety of tumors and plays an active role in promoting growth and metastasis of tumor cells. (biomedcentral.com)
Co-immunoprecipitation assay was applied for detecting the endogenous interaction of MAGEC2 and TRIM28 in tumor cells. (biomedcentral.com)
We demonstrate that MAGEC2 interacts with TRIM28 in melanoma cells and MAGEC2 expression in tumor cells depends on the expression of TRIM28. (biomedcentral.com)
The expression level of MAGEC2 protein was significantly reduced when TRIM28 was depleted in tumor cells, and no changes were observed in MAGEC2 mRNA level. (biomedcentral.com)
Mechanistic studies indicate that the regulatory role of TRIM28 on MAGEC2 protein expression in tumor cells depends on proteasome-mediated pathway. (biomedcentral.com)
In this study, we found that expression of MAGEC2 protein in tumor cells depends on the expression of TRIM28, a reduction in the level of endogenous TRIM28 expression in melanoma cells resulting in significantly decreased expression of MAGEC2 protein. (biomedcentral.com)
Decreased antigen presentation contributes to the ability of cancer cells to evade the immune system. (lu.se)
We used the minimal gene regulatory network of type 1 conventional dendritic cells (cDC1) to reprogram cancer cells into professional antigen-presenting cells (tumor-APCs). (lu.se)
Within 9 days of reprogramming, tumor-APCs acquired transcriptional and epigenetic programs associated with cDC1 cells. (lu.se)
Reprogramming restored the expression of antigen presentation complexes and costimulatory molecules on the surfaces of tumor cells, allowing the. (lu.se)
Our approach serves as a platform for the development of immunotherapies that endow cancer cells with the capability to process and present endogenous tumor antigens. (lu.se)
Reprogramming cancer cells to antigen-presenting cells. (lu.se)
Data from in vitro translation experiments and transfection of melanoma cells with bicistronic vectors documented that MELOE-3 is exclusively translated by the classical cap-dependent pathway. (oncotarget.com)
Using a sensitive tandem mass spectrometry technique, we detected the presence of MELOE-3 in total lysates of both melanoma cells and normal melanocytes. (oncotarget.com)
Flow cytometric analysis of Chondroitin Sulfate expressed on M21 human melanoma cells. (bdbiosciences.com)
Clone 9.2.27 has been shown to react with human melanoma cells, glioma cells, and proliferating brain endothelial cells. (bdbiosciences.com)
NK cells coordinate tumor immunosurveillance and the immune response against pathogens. (scielo.br)
The company is hoping BNT111, which used a fixed combination of mRNA-encoded, tumor-associated antigens to target the cancer cells, will demonstrate the same kind of success as the COVID-19 vaccine. (biospace.com)
Many tumor cells produce antigens, which may be released in the bloodstream or remain on the cell surface. (msdmanuals.com)
Tumor-associated antigens (TAAs) are relatively restricted to tumor cells. (msdmanuals.com)
Tumor-specific antigens (TSAs) are unique to tumor cells. (msdmanuals.com)
References Many tumor cells produce antigens, which may be released in the bloodstream or remain on the cell surface. (msdmanuals.com)
From here, the antigen is slowly released and provided to immune cells over an extended period of time. (mdpi.com)
In 1989, Zelig Eshhar and colleagues realized that the inability of T cells to recognize surface tumour antigens could be overcome by replacing domains of the T cell receptor (TCR) with antibody parts with specificity towards proteins on these cells. (nature.com)
The T cells expressing CARs recognized and eliminated target cells, and produced interleukin 2 in the presence of the antigen, providing a proof of concept that this approach triggers a cellular immune response. (nature.com)
Physiologic recognition of tumour antigens by T cells is mediated by the TCR-CD3 complex. (nature.com)
In 2010, James Kochenderfer and colleagues achieved a breakthrough with a CAR T cell therapy, reporting tumour regression in a patient with advanced follicular lymphoma, who received two infusions of autologous T cells genetically engineered to express a CAR specifically recognizing the antigen CD19 expressed on B cells. (nature.com)
Another ACT developed in parallel to CAR T cells is engineering T cells to express TCRs that recognize tumour-associated antigens. (nature.com)
In 2006, Rosenberg and colleagues transferred TCR T cells specifically recognizing the melanoma antigen MART-1 in 15 patients, two of whom achieved regression and still showed high levels of engineered cells in circulation one year after the infusion. (nature.com)
Furthermore, there is an absence of a cellular hierarchy in cell lines and all cells in culture are able to drive tumor progression. (whiterose.ac.uk)
Lukas Bunse, a scientist at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and a physician at the University Medical Center Mannheim, relies on the comparatively new concept of "T cell receptor transgenic cells" in his current study: To this end, brain tumor patients were first inoculated with an antigenic fragment of the protein NLGN4X (Neuroligin4X). (dkfz.de)
Bunse's team then isolated from the blood of the vaccinated individuals those T cells that had been activated by NLGN4X and consequently carried a T cell receptor that specifically "recognizes" this glioblastoma-associated antigen. (dkfz.de)
In this way, they succeeded in producing large numbers of T cells with identical specificity, all of which recognize the cancer antigen NLGN4X. (dkfz.de)
Bunse's team then demonstrated that the NLGN4X-specific T cells are able to kill brain tumor cells in the culture dish. (dkfz.de)
Brain tumor-bearing mice treated with transgenic NLGN4X-specific human T cells had a greater than 40 percent response to treatment. (dkfz.de)
Much more advanced in clinical development than T-cell receptor transgenic cells are cellular therapies using so-called CAR-T (chimeric antigen receptor) cells, which have already been approved for the treatment of various leukemias and lymphomas. (dkfz.de)

Libtayo, a monoclonal antibody, has previously been approved to treat metastatic cutaneous squamous cell carcinoma, advanced basal cell carcinoma, and patients with advanced non-small-cell lung cancer whose tumors have high PD-L1 expression. (biospace.com)
The inhibition of two immune checkpoints, LAG-3 using relatlimab and PD-1, improved progression-free survival (PFS) to a greater extent than inhibition of PD-1 alone in patients with previously untreated metastatic or unresectable melanoma. (biomedcentral.com)
These results support the synergistic effect of dual checkpoint inhibition over monotherapy and identify relatlimab-nivolumab as a potential new treatment option for patients with previously untreated metastatic or unresectable melanoma. (biomedcentral.com)
Several of these therapies are already FDA-approved for treating metastatic melanoma. (biomedcentral.com)

Classic warning signs and symptoms of melanoma include any cutaneous lesion that changes color, size, or shape. (medscape.com)
The prognosis for and treatment of cutaneous melanoma depend greatly on the thickness of the lesion. (medscape.com)
Despite declines in the overall incidence of cancer and the associated mortality rate, the incidence of cutaneous melanoma continues to escalate, with the National Cancer Institute (NCI) reporting that the rate of new cases of melanoma of the skin has been increasing by an average of 1.5% annually. (medscape.com)
According to BioNTech, those antigens are expressed in more than 90% of cutaneous melanomas. (biospace.com)
Oral melanomas are uncommon (1.2 cases per 10 million population per year in the United States), and, similar to their cutaneous counterparts, they are thought to arise primarily from melanocytes in the basal layer of the squamous mucosa. (medscape.com)
In contrast to cutaneous melanomas, which are etiologically linked to sun exposure, risk factors for mucosal melanomas are unknown. (medscape.com)

The field of Lymphocyte Surface Antigens and Activation Mechanisms is examined in two chapters. (scielo.br)
We have studied the transgenic mouse strain, Tyrp-1-TAg, to try to gain insight into possible molecular mechanisms common to pigmented ocular neoplasms occurring spontaneously in the eyes of these mice and human choroidal melanoma. (molvis.org)
This offers significant advantages for studying tumor pathogenesis and molecular mechanisms of oncogenesis caused by a single initiating oncogenic event introduced through the mouse germ line. (molvis.org)

The mRNA vaccines can encode multiple antigens, strengthening the immune response against pathogens and enabling the targeting of multiple microbial variants [19] . (researchgate.net)

According to the American Cancer Society, approximately 99,780 new melanomas were expected to be diagnosed in the United States in 2022, including about 57,180 in men and 42,600 in women. (medscape.com)
[ 2 ] The American Cancer Society estimates that 7650 people will die from melanoma in 2022. (medscape.com)
This year, the Melanoma Bridge Congress (Dec 1st-3rd, 2022, Naples, Italy) addressed the latest advances in melanoma research, focusing on themes of paramount importance for melanoma prevention, diagnosis and treatment. (biomedcentral.com)

Antitumor immunity elicited by tumor-APCs was synergistic with immune checkpoint inhibitors. (lu.se)

This upregulation was correlated with tumor progression. (molvis.org)
In this cohort study of 94 patients with resected melanoma brain metastases that underwent targeted DNA sequencing, BRAF V600E variant lesions were associated with worse intracranial progression-free survival and overall survival. (cdc.gov)

Purpose: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and approximately half of those diagnosed will die of metastasis. (whiterose.ac.uk)
Relevant mouse models of human uveal melanoma still remain to be developed. (molvis.org)

This occurs because each T cell is endowed with a highly specific receptor that can bind to an antigen present at the surface of another cell. (wikipedia.org)
Evidence has recently been obtained that two very different recombinatorial systems for lymphocyte antigen receptor diversification appeared at the beginning of vertebrate evolution approximately 500 million years ago. (scielo.br)
According to the scientist, it is also conceivable to generate T cell receptor transgenic cell therapies against patient-individual cancer antigens. (dkfz.de)

The role of two members of the ETS (E26 avian leukemia oncogene) family of transcription factors, ETS-1 and ETS-2, has been investigated in many cancers but has not yet been studied in ocular tumors. (molvis.org)

Research has intensified to understand ERV protein function and their role as tumor antigens and targets for cancer (immune) therapy. (frontiersin.org)
Several oncogenes have been identified as potential targets for molecularly targeted melanoma therapy, such as tyrosine kinase inhibitors (TKIs). (biomedcentral.com)

The directed expression of SV40 T antigen has led to the development of several important transgenic models with spontaneous epithelial tumor formation. (molvis.org)

BNT111 is the lead product candidate from BioNTech's own FixVac platform and is currently being assessed in a Phase II study in patients with anti-PD-1-refractory/relapsed unresectable Stage III or IV melanoma. (biospace.com)
In the ongoing Phase II study in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma, BNT111 is paired with Libtayo , a checkpoint inhibitor developed by Regeneron and Sanofi . (biospace.com)

MELOE-1 and MELOE-2, two highly specific melanoma antigens involved in T cell immunosurveillance are produced by IRES-dependent translation of the long « non coding » and polycistronic RNA, meloe . (oncotarget.com)

Unlike cancer arising in the human population, tumors in genetically engineered mouse models arise in mice with well defined genetic backgrounds where genetic variability can be minimized. (molvis.org)

Methods Peripheral blood T cell stimulation by NY-ESO-1 and Melan-A overlapping peptide libraries was assessed before and during ICB in two independent cohorts of a total of 111 patients with stage IV melanoma. (bmj.com)
In this respect, the choice of the targeted antigens remains a critical issue [ 2 ] and the ideal antigen(s) should have the following characteristics : be as tumor specific as possible and stimulate a broad T cell repertoire in the majority of patients (i.e. generate many epitopes in various HLA contexts). (oncotarget.com)
The number of new combinations treatment under development for melanoma provides options for the number of patients to achieve a therapeutic benefit. (biomedcentral.com)
To bypass resistance, combination treatment with immunotherapies and single or multiple TKIs have been shown to improve the prognosis of melanoma patients compared to monotherapy. (biomedcentral.com)

The Fast Track Designation underlines the potential of our FixVac platform to address current treatment challenges of pre-treated and immune checkpoint blocker experienced melanoma with limited standard of care therapy options left. (biospace.com)

Genetic processes other than point mutations can lead to tumor-specific antigens. (wikipedia.org)
BRAF inhibitors, MEK inhibitors, NRAS inhibitors, and cKIT inhibitors all have the potential for targeting melanomas that have gene mutations affecting the MAPK-ERK pathway. (medscape.com)

Methods: Expression of postulated stem cell markers aldehyde dehydrogenase (ALDH), CD44, and CD133 was analyzed in UM cell lines and primary UM short-term cultures (STCs) established from tumor samples. (whiterose.ac.uk)

In addition to acquiring improved antigen presentation, tumor-APCs had impaired tumorigenicity in vitro and in vivo. (lu.se)
Injection of in vitro generated melanoma-derived tumor-APCs into subcutaneous melanoma tumors delayed tumor growth and increased survival in mice. (lu.se)

Digital pathology analysis was performed to quantify NY-ESO-1 and Melan-A expression by tumors. (bmj.com)
High ERV-K env total protein expression of all tumor subtypes significantly correlated with low tumor grading and a longer disease specific survival using multivariable analyses. (frontiersin.org)
To our knowledge, this is the first time to report the role of TRIM28 in regulating the expression of cancer/testis antigen MAGEC2. (biomedcentral.com)
Enforced expression of the transcription factors PU.1, IRF8, and BATF3 (PIB) was sufficient to induce the cDC1 phenotype in 36 cell lines derived from human and mouse hematological and solid tumors. (lu.se)
This contrasts with our previous observation of the melanoma-restricted expression of MELOE-1 and MELOE-2. (oncotarget.com)

Sixteen histological tumor subtypes exist and the most common are papillary, chromophobe and clear cell renal cell carcinoma (ccRCC) representing 85% of all RCC. (frontiersin.org)
Nanovaccines can improve antigen presentation, targeted delivery, stimulation of the body's innate immune system, and a strong T-cell response without putting people at risk. (researchgate.net)
The hybridoma secreting the 9.2.27 antibody was generated using a human melanoma cell extract as the immunogen. (bdbiosciences.com)
This approach offers the advantage of targeting antigens not present on the cell surface. (nature.com)

In this investigation a human RCC tissue microarray (TMA) (n=374) predominantly consisting of the most common histological tumor subtypes was hybridized with an ERV-K env antibody and correlated with patient clinical data. (frontiersin.org)
Genetic basis for clinical response to CTLA-4 blockade in melanoma. (msdmanuals.com)

Staging of the melanoma adheres to the traditional tumor-node-metastasis (TNM) classification system. (medscape.com)

The diagnosis is oral melanoma. (medscape.com)

This study supports ERV-K env as a single prognostic indicator for better survival of RCC, which we propose represents a new tumor antigen. (frontiersin.org)

Predicting tumor response to PD-1 blockade. (msdmanuals.com)

However, although treatment with TILs was effective in some tumours (such as melanoma), the lack of specificity and the difficulty in recruiting TILs from most other cancer types compromised the therapeutic potential. (nature.com)

Multiple studies have examined the issue of the optimal dose of radiotherapy in NSCLC but are complicated by the heterogeneity of the disease itself in terms of size and location of the primary tumor, number and size of involved lymph nodes, and the patient's comorbidities, all of which limit the treatment tolerability and risks. (frontiersin.org)
Delivery of tumoricidal doses to the primary tumor and involved lymph nodes is balanced by treatment-related toxicities, namely esophagitis, pneumonitis, and cardiac injury. (frontiersin.org)

Anatomy21

Organisms12

Diseases39

Chemicals and Drugs107

Analytical, Diagnostic and Therapeutic Techniques and Equipment40

Phenomena and Processes41

Disciplines and Occupations1

Information Science3

Health Care6

Lymphocytes6

Genes9

Malignant6

Immunogenicity2

Antibodies6

Variety of antigens1

ImmunoTherapy6

Anti-tumor immune3

Surface of tumor cells2

Responses7

Receptors4

Treatment of melanoma2

Cells46

Metastatic4

Cutaneous6

Mechanisms3

MRNA1

20223

Antitumor immunity1

Progression2

Uveal2

Receptor3

Cancers1

Targets2

Spontaneous1

Unresectable2

Immunosurveillance1

Genetically engineered1

Patients4

Checkpoint1

Mutations2

Methods1

Vitro2

Expression5

Cell4

Clinical2

Metastasis1

Diagnosis1

Survival1

Blockade1

Specificity1

Primary2